Form 4 holding
Director
Arch Therapeutics, Inc.
- Security class
- Warrants (right to buy)
- Shares / value
- 20,584
- Estimated value
- Report date
- 31 Aug 2023
- Price
- Ownership
- Drake Partners
- Underlying class
- Common Stock
- Underlying amount